Valuation (9%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -6.16 | 47.65 |
PEG Ratio (TTM) | -0.73 | -0.78 |
P/S Ratio (TTM) | 2.59 | 6.17 |
P/B Ratio (TTM) | 18.62 | 6.12 |
P/FCF Ratio (TTM) | -10.78 | 42.55 |
Price to 5YR AVG Earnings Ratio | N/A | 59.84 |
Price to 5YR AVG FCF Ratio | N/A | 34.62 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -31.67% | 5.37% |
ROE (TTM) | -195.26% | 28.10% |
Net Profit Margin (TTM) | -41.63% | 7.71% |
ROIC 5YR AVG | N/A | 6.76% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 4.93% | -10.24% | N/A |
Revenue | 4.00% | 7.28% | N/A |
Net Income | 1.72% | -11.43% | N/A |
Cash Flow | -18.77% | -16.70% | N/A |
Health (37%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 6.37 | 2.87 |
Quick Ratio (TTM) | 5.47 | 2.15 |
D/E Ratio (TTM) | 6.15 | 0.62 |
Interest Coverage (TTM) | -2.80 | 22.83 |
Piotroski F-Score | 4 | 6 |
Altman Z-Score | N/A | 7.62 |
LTL to 5YR AVG FCF | N/A | 3.48 |
Shares Outstanding Growth 5YR AVG | N/A | 1.62% |